Improving recovery after surgery for neurocritical care patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and efficacy of an Enhanced Recovery After Surgery (ERAS) protocol specifically designed for patients in neurocritical care, including those with traumatic brain injury and cerebrovascular disease. The ERAS approach focuses on optimizing perioperative management to reduce complications, promote faster recovery, and decrease hospital stays. By implementing evidence-based practices, the study aims to enhance patient outcomes in neurosurgical intensive care settings. The research will compare the ERAS protocol to conventional therapy to assess its effectiveness.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18-75 years old
* Patients with moderate or severe acute traumatic brain injury or cerebrovascular disease requiring neurosurgical intensive care treatment
* Hospitalization time ≥ 1 week
* The guardian is able to understand and actively cooperate in completing the project
* The guardian signs an informed consent form

Exclusion Criteria:

* Patients undergoing non-surgical treatment
* Patients diagnosed as brain death within the first 24 hours after admission to NICU
* Patients undergoing cardiopulmonary resuscitation, maintenance dialysis, end-stage tumors, and disseminated cancer
* Patients who withdraw treatment during hospitalization or are discharged automatically
* Patients who underwent unplanned secondary surgery during the research process
* Individuals who cannot be followed up during the research process

Where it's running

• Shanghai 6th People's Hospital
  Shanghai, China Recruiting

Study contacts

• Study coordinator: Hao Chen, M.D., Ph.D.
• Email: hao.chen@shsmu.edu.cn
• Phone: 8602164369181

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Neutral fluid balance in adults with traumatic brain injury (LIMIT-TBI)

  This study tests whether keeping daily fluid balance around zero (within 500 mL) for the first 5 days in the ICU is feasible and safe for adults with traumatic brain injury.

  Recruiting at 3 sites Phase 2 Erasme University Hospital · Brussels and 2 other locations · NCT07625995

• Semi-elemental tube feeding to improve gut tolerance after severe traumatic brain injury

  This will test whether starting semi-elemental tube feeding within 48 hours reduces gastrointestinal intolerance in adults with severe traumatic brain injury.

  Recruiting Tang-Du Hospital · Xi'an, Shaanxi · NCT07092423

• Brain recovery after MCA reopening is studied with PET/MR

  This study tests how brain blood flow, metabolism, and networks change after reopening a non-acute atherosclerotic middle cerebral artery occlusion in adults receiving recanalization treatment.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07927569

• PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury

  This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.

  Recruiting at 3 sites University of Michigan · Torrance, California and 4 other locations · NCT07858266

• HBOT to see if it helps cognition and well‑being in first responders with prior brain injury

  This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07852728

• Depth Electrode Monitoring after Traumatic Brain Injury

  This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.

  Recruiting Hennepin Healthcare Research Institute · Minneapolis, Minnesota · NCT07842458

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.